-
Abstract Number: 1125
Non-Classical Complications of Adult-Onset Still’s Disease: A Multicenter Spanish Study
-
Abstract Number: 1126
The Outcomes of Carpal Tunnel Injections and Carpal Tunnel Surgery
-
Abstract Number: 1127
Risk of Ocular Inflammatory Conditions in Patients with Autoimmune Diseases: A Retrospective Study Using the National Inpatient Sample
-
Abstract Number: 1128
A Meta-Analysis of Statin Efficacy in Controlling Disease Activity in Psoriasis
-
Abstract Number: 1129
Machine Learning Algorithms to Predict Colchicine Resistance in Familial Mediterranean Fever
-
Abstract Number: 1130
Safety of Bispecific T-cell Engager Therapy in Autoimmune Disease
-
Abstract Number: 1131
Zasocitinib (TAK-279), a Selective Oral Tyrosine Kinase 2 Inhibitor, Reduces Body Surface Area Involvement in a Phase 2b Trial in Moderate-to-Severe Plaque Psoriasis
-
Abstract Number: 1132
Guselkumab and Golimumab Combination Induction Therapy in Ulcerative Colitis Results in Early Local Tissue Healing That Is Sustained Through Guselkumab Maintenance Therapy
-
Abstract Number: 1133
Relationship Between Nail Psoriasis Severity Index (NAPSI) and Cardiovascular Risk Assessed by Eight Cardiovascular Risk Calculators
-
Abstract Number: 1134
First-in-Human Evaluation of the Safety, Tolerability and Pharmacokinetics of the T Cell Receptor Signal Modulator AX-158
-
Abstract Number: 1135
Deucravacitinib in Plaque Psoriasis: 4-Year Efficacy Results by Prior Biologic Treatment in the Phase 3 POETYK PSO-1, PSO-2, and Long-Term ExtensionTrials
-
Abstract Number: 1136
Efficacy And Safety of Guselkumab Therapy in Patients With Moderately to Severely Active Crohn’s Disease: Results of the Galaxi 2 & 3 Phase 3 Studies
-
Abstract Number: 1137
Deucravacitinib, an Oral,Selective,Allosteric Tyrosine Kinase 2 Inhibitor, in Patients WithModerate to Severe Scalp Psoriasis: Efficacy and Safety Results of a Phase 3b/4, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial (PSORIATYK SCALP)
-
Abstract Number: 1138
Association Between Long-Term Exposure to Fine Particles and Its Components and the Onset of Systemic Autoimmune Rheumatic Diseases in Quebec
-
Abstract Number: 1139
Comprehensive Single-cell Profiling of Diverse Circulating Immune Cells in Idiopathic Inflammatory Myopathies Identifies a Novel Pathogenic Subset of Monocytes
- « Previous Page
- 1
- …
- 75
- 76
- 77
- 78
- 79
- …
- 181
- Next Page »